Overland ADCT BioPharma appoints Eric Koo as CEO

– CHINA, Shanghai / USA, MA / SWITZERLAND, Lausanne –  Overland ADCT BioPharma, a joint venture created by Overland Pharmaceuticals and ADC Therapeutics SA (NYSE: ADCT), today announced the appointment of Eric Ko as CEO, bringing more than 25 years of the pharmaceutical industry and business management experience to the company with a proven track record of executing successful drug approvals and launches across Asia.…

36Kr Holdings appoints Hao Lan to its Board of Directors

– CHINA, Beijing –  36Kr Holdings Inc. (NASDAQ: KRKR), a prominent brand and pioneering platform dedicated to serving New Economy participants in China, today announced the appointment of Hao Lan to its Board of Directors effective April 1, 2021.…